2-(3-Methylbut-2-en-1-yl)isoindoline-1,3-dione

Catalog No. :
ACGEMT845
CAS No. :
15936-45-5
Molecular Formula :
C13H13NO2
Molecular Weight :
215.25

IUPAC Name:2-(3-methylbut-2-en-1-yl)isoindoline-1,3-dione

2-(3-Methylbut-2-en-1-yl)isoindoline-1,3-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$312.00Login to see priceInquiryInquiry
250mg95%$420.00Login to see priceInquiryInquiry
1g95%$1117.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(3-Methylbut-2-en-1-yl)isoindoline-1,3-dione
IUPAC Name2-(3-methylbut-2-en-1-yl)isoindoline-1,3-dione
MDL No.MFCD00158680
Molecular FormulaC13H13NO2
Molecular Weight215.25
SMILESO=C1N(C/C=C(C)\C)C(C2=C1C=CC=C2)=O
InChI KeyNPPJFTLLMRKUHM-UHFFFAOYSA-N
SynonymN-(3-METHYL-2-BUTEN-1-YL)PHTHALIMIDE;2-(3-methylbut-2-enyl)isoindoline-1,3-dione;N-(3-Methyl-2-butenyl)phthalimide;2-(3-Methylbut-2-en-1-yl)isoindoline-1,3-dione;1H-Isoindole-1,3(2H)-dione, 2-(3-methyl-2-buten-1-yl)-;2-(3-methylbut-2-en-1-yl)-2,3-dihydro-1H-isoindole-1,3-dione
CAS No.15936-45-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P264-P270-P301+P312-P330-P501

Synthetic Route by SureRoute

1. ACGEMT845 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJDOI249 route compound structure diagram
    ACJDOI2491074-82-4 In Stock
  4. Then
  5. ACGEMT845 route product structure diagram
    ACGEMT84515936-45-5
Inquiry

2. ACGEMT845 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJDOI249 route compound structure diagram
    ACJDOI2491074-82-4 In Stock
  4. Then
  5. ACGEMT845 route product structure diagram
    ACGEMT84515936-45-5
Inquiry

Comments (0)